IRVINE, CA -- (MARKET WIRE) -- September 21, 2006 -- BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today that President and CEO Jeffrey W. Jones and CFO Richard L. Harrison are scheduled to make an investor presentation at the UBS Global Life Sciences Conference at 2:30 p.m. (Eastern) on Tuesday, September 26.
